Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent, or metastatic cervical cancer: KEYNOTE-826
Kan Yonemori,Shin Nishio,Tomoka Usami,Shinichiro Minobe,Mayu Yunokawa,Takashi Iwata,Aikou Okamoto,Yoichi Aoki,Hiroaki Itamochi,Munetaka Takekuma,Kenichi Harano,Keiko Yamamoto,Hiroyuki Ugai,Cumhur Tekin,Sarper Toker,Nicoletta Colombo,Keiichi Fujiwara,Kosei Hasegawa ANNALS OF ONCOLOGY（2022）
AI 理解论文
溯源树
样例
